Halozyme Therapeutics (HALO)
NASDAQ:HALO
Want to see HALO full AI Analyst Report?
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 10, 2026 | xxxxxxxxxxxxx | $1955137 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $287909 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $433883 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $3533250 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $4509100 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,894,653 | Institution | 10.88% | 874,515,366 | |
| 10,166,012 | Institution | 8.58% | 689,458,934 | |
| 9,133,567 | Institution | 7.71% | 619,438,514 | |
| 3,531,379 | Institution | 2.98% | 239,498,124 | |
| 3,330,835 | Institution | 2.81% | 225,897,230 | |
| 1,374,284 | Institution | 1.16% | 93,203,941 | |
| 1,366,376 | Institution | 1.15% | 92,667,620 | |
| 1,175,300 | Institution | 0.99% | 79,708,846 | |
| 1,156,605 | Institution | 0.98% | 78,440,951 | |
| 1,101,354 | Institution | 0.93% | 74,693,828 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,133,567 | Institution | 7.71% | 619,438,514 | |
| 3,330,835 | Institution | 2.81% | 225,897,230 | |
| 1,175,300 | Institution | 0.99% | 79,708,846 | |
| 1,156,605 | Institution | 0.98% | 78,440,951 | |
| 1,101,354 | Institution | 0.93% | 74,693,828 | |
| 1,094,930 | Institution | 0.92% | 74,258,153 | |
| 1,027,105 | Institution | 0.87% | 69,658,261 | |
| 857,921 | Institution | 0.72% | 58,184,202 | |
| 775,438 | Institution | 0.65% | 52,590,205 | |
| 760,014 | Institution | 0.64% | 51,544,149 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,200,163 | Institution | 3.55% | 138,017,356 | |
| 3,948,725 | Institution | 3.33% | 267,802,530 | |
| 3,708,005 | Institution | 3.13% | 257,817,588 | |
| 2,670,804 | Institution | 2.25% | 185,701,002 | |
| 1,483,084 | Institution | 1.25% | 103,118,831 | |
| 1,410,941 | Institution | 1.19% | 94,645,922 | |
| 1,281,191 | Institution | 1.08% | 89,081,210 | |
| 1,112,843 | Institution | 0.94% | 75,473,012 | |
| 893,674 | Institution | 0.75% | 60,608,971 | |
| 874,823 | Institution | 0.74% | 59,330,496 |
FAQ
Who Owns Halozyme Therapeutics (HALO)?
Currently, no data Available
What percentage of Halozyme Therapeutics (HALO) stock is held by institutional investors?
Currently, no data Available
What percentage of Halozyme Therapeutics (HALO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Halozyme Therapeutics (HALO)?
iShares owns the most shares of Halozyme Therapeutics (HALO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.